{"transactions":[{"id":674527,"issuer":{"id":7442,"kind":"organization","name":"Estrella Immunopharma, Inc."},"owners":[{"id":19350,"kind":"person","name":"Liu Cheng","position":1,"cik":"0001996255","reported_name":"Liu Cheng","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Incentive Stock Option","published_at":"2026-08-26T23:23:37.000Z","date":"2026-08-25","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents incentive share options granted to the Reporting Person on October 30, 2024 under the Issuer's 2023 Omnibus Incentive Plan, of which twenty-five percent (25%) was immediately exercisable on the date of grant, with the remainder vesting in equal monthly installments of 1/48th of the total award on each monthly anniversary of October 30, 2024. The options were vested as to the shares exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable. The reported transaction is the exercise of the stock option for the exercise price set forth in Column 2. No separate consideration was paid or received for the derivative security."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents incentive share options granted to the Reporting Person on October 30, 2024 under the Issuer's 2023 Omnibus Incentive Plan, of which twenty-five percent (25%) was immediately exercisable on the date of grant, with the remainder vesting in equal monthly installments of 1/48th of the total award on each monthly anniversary of October 30, 2024. The options were vested as to the shares exercised."}],"balance_after":900000,"derivative":{"exercise_price":0.815,"exercise_date":"2024-10-31","expiration_date":"2034-10-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001996255-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1844417/000199625526000004/primary_doc.xml","form_type":"4"}},{"id":674526,"issuer":{"id":7442,"kind":"organization","name":"Estrella Immunopharma, Inc."},"owners":[{"id":19350,"kind":"person","name":"Liu Cheng","position":1,"cik":"0001996255","reported_name":"Liu Cheng","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-26T23:23:37.000Z","date":"2026-08-25","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0.815,"value":81500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the exercise price per share paid by the Reporting Person upon the exercise of the stock options reported in Table II."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the 297,437 shares of Common Stock directly beneficially owned as reported on the Reporting Person's most recent Form 4, plus the 100,000 shares acquired upon the reported exercise."}],"balance_after":397437,"source":{"system":"sec-edgar","filing":"0001996255-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844417/000199625526000004/primary_doc.xml","form_type":"4"}},{"id":1266538,"issuer":{"id":7442,"kind":"organization","name":"Estrella Immunopharma, Inc."},"owners":[{"id":19350,"kind":"person","name":"Liu Cheng","position":1,"cik":"0001996255","reported_name":"Liu Cheng","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Nonstatutory Share Option","published_at":"2025-02-14T21:30:20.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":509204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The incentive share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The incentive share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The nonstatutory share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024."}],"balance_after":509203,"derivative":{"exercise_price":0.815,"exercise_date":"2024-10-31","expiration_date":"2034-10-29","underlying":"Common Stock","underlying_shares":509204},"source":{"system":"sec-edgar","filing":"0001213900-25-014310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025014310/ownership.xml","form_type":"4"}},{"id":1266537,"issuer":{"id":7442,"kind":"organization","name":"Estrella Immunopharma, Inc."},"owners":[{"id":19350,"kind":"person","name":"Liu Cheng","position":1,"cik":"0001996255","reported_name":"Liu Cheng","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Incentive Share Option","published_at":"2025-02-14T21:30:20.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":490796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 30, 2024, the Board of Directors (the \"Board\") of Estrella Immunopharma, Inc. (the \"Company\"), awarded Mr. Cheng Liu an incentive share option grant of 490,796 shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 30, 2024, the Board of Directors (the \"Board\") of Estrella Immunopharma, Inc. (the \"Company\"), awarded Mr. Cheng Liu an incentive share option grant of 490,796 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 30, 2024, the Board of the Company awarded Mr. Liu a nonstatutory shares option grant of 509,204 shares."}],"balance_after":490796,"derivative":{"exercise_price":0.815,"exercise_date":"2024-10-31","expiration_date":"2034-10-29","underlying":"Common Stock","underlying_shares":490796},"source":{"system":"sec-edgar","filing":"0001213900-25-014310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025014310/ownership.xml","form_type":"4"}}]}